Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lilianna Wislocka"'
Autor:
Uwe Pelzer, Fritz Klein, Lilianna Wislocka, Hanno Riess, Tim Denecke, Jana K. Striefler, Marcus Bahra, Marianne Sinn, Anja Jühling, Josefine Roemmler-Zehrer
Publikováno v:
European Journal of Cancer. 100:85-93
Introduction Treatment of patients with advanced pancreatic carcinoma (APC) and hyperbilirubinaemia is problematic because these patients were regularly excluded from clinical studies. Nanoparticle albumin–bound paclitaxel and gemcitabine (nab-P/G)
Autor:
Jana K. Striefler, Fritz Klein, Bruno Valentin Sinn, Marianne Sinn, Philipp Lohneis, Anja Jühling, Hanno Riess, Sven Bischoff, Uwe Pelzer, Hendrik Bläker, Carsten Denkert, Lilianna Wislocka, Helmut Oettle
Publikováno v:
British Journal of Cancer
Background The prognostic effect of tumour budding was retrospectively analysed in a cohort of 173 patients with resected pancreatic ductal adenocarcinomas (PDACs) of the prospective clinical multicentre CONKO-001 trial. Methods Haematoxylin and eosi
Autor:
Sven Bischoff, Hanno Riess, M. de Wit, Eike Wolter, Marianne Sinn, Anja Jühling, C. Pollich, Lilianna Wislocka, Piet Habbel, Robert Klamroth, Christian W. Scholz, Ernst Spaeth-Schwalbe
Publikováno v:
Thrombosis Research. 200:S36-S37
Autor:
Hanno Riess, Marcus Bahra, Hendrik Bläker, Helmut Oettle, Uwe Pelzer, Marianne Sinn, Bruno Valentin Sinn, Korinna Jöhrens, Anja Jühling, Carsten Denkert, Lilianna Wislocka, Sven Bischoff, Jana K. Striefler, Philipp Lohneis
Publikováno v:
European Journal of Cancer. 83:290-301
Background We studied the prognostic effect of CD3-, CD8- and CD103-positive T lymphocytes in a cohort of 165 patients with resected pancreatic ductal adenocarcinomas (PDACs) of the treatment group (adjuvant gemcitabine) and the untreated control gro
Autor:
Hanno Riess, C. Pollich, Piet Habbel, Marianne Sinn, M. Orlovic, Lilianna Wislocka, C. Leng, M. de Wit, Christian W. Scholz, Anja Jühling, Sven Bischoff, E. Späth-Schwalbe, E. Wolters, Robert Klamroth
Publikováno v:
Science meets clinical practice.
Autor:
Bernd Dörken, Hendrik Bläker, Philipp Lohneis, Marcus Bahra, Hanno Riess, Marianne Sinn, Anja Jühling, Bruno Valentin Sinn, Helmut Oettle, Uwe Pelzer, Carsten Denkert, Lilianna Wislocka, Jana K. Striefler
Publikováno v:
Pathology - Research and Practice. 212:726-734
In pancreatic cancer there is a need for prognostic risk stratification and subsequent therapy strategies. Molecular analysis has shown in different cancers that variation in clinical behavior can be associated with specific alterations. The cell cyc
Autor:
Sven Bischoff, Eike Wolter, Marianne Sinn, Lilianna Wislocka, Christian W. Scholz, Christiane Pollich, Piet Habbel, Maike de Wit, Klamroth, Ernst Spaeth-Schwalbe, Anja Jühling, Hanno Riess
Publikováno v:
Blood. 134:4969-4969
Background: National and international guidelines for the diagnosis and treatment of cancer associated venous thromboembolism (CAT) recommend anticoagulation treatment for 3 to 6 months and a re-evaluation for resumption depending on the individual r
Autor:
Helmut Oettle, Sven Bischoff, Jana K. Striefler, Lilianna Wislocka, Uwe Pelzer, Philipp Lohneis, Marianne Sinn, Carsten Denkert, M Bahra, B. Hendrik, Hanno Riess, A. Juehling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23179a56e6c63fcfd7d22a55df68751d
https://europepmc.org/articles/PMC4984155/
https://europepmc.org/articles/PMC4984155/
Autor:
Jana K. Striefler, Anja Jühling, Bruno Valentin Sinn, Hanno Riess, Lilianna Wislocka, Philipp Lohneis, Uwe Pelzer, Sven Bischoff, Helmut Oettle, Korinna Jöhrens, Carsten Denkert, Hendrik Blaeker, Marianne Sinn
Publikováno v:
Journal of Clinical Oncology. 35:281-281
281 Background: The role of T lymphocytes, frequently found in the tumor microenvironment, on development and behavior of several solid tumors is well recognized. Studies on breast cancer and colon carcinoma showed the prognostic and predictive impac
Autor:
Marianne Sinn, Jana K. Striefler, Hanno Riess, Sven Bischoff, Lilianna Wislocka, Bernd Dörken, Anja Jã ¼hling, Uwe Pelzer, Marcus Bahra
Publikováno v:
Journal of Clinical Oncology. 34:e15717-e15717
e15717Background: The combination of nabpaclitaxel/gemcitabine (AG) is one standard of care treatment for patients (pts) with advanced pancreatic adenocarcinoma (APC). Only insufficient data accord...